IRIS
PASTA, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.250
NA - Nord America 1.290
AS - Asia 1.122
SA - Sud America 90
AF - Africa 19
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.777
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 3.041
US - Stati Uniti d'America 1.193
SG - Singapore 350
CN - Cina 307
BD - Bangladesh 196
VN - Vietnam 176
FR - Francia 60
BR - Brasile 56
CA - Canada 56
FI - Finlandia 39
HK - Hong Kong 34
DE - Germania 27
AR - Argentina 22
GB - Regno Unito 21
MX - Messico 13
NL - Olanda 10
JP - Giappone 9
ID - Indonesia 8
IN - India 8
IE - Irlanda 7
UA - Ucraina 6
AT - Austria 5
ES - Italia 5
JM - Giamaica 5
NI - Nicaragua 5
PH - Filippine 5
PL - Polonia 5
AU - Australia 4
EG - Egitto 4
HN - Honduras 4
IQ - Iraq 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
CH - Svizzera 3
CR - Costa Rica 3
EC - Ecuador 3
MY - Malesia 3
PT - Portogallo 3
RU - Federazione Russa 3
AZ - Azerbaigian 2
BE - Belgio 2
CL - Cile 2
CO - Colombia 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
ET - Etiopia 2
GP - Guadalupe 2
KE - Kenya 2
MA - Marocco 2
NP - Nepal 2
OM - Oman 2
SA - Arabia Saudita 2
SE - Svezia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
VE - Venezuela 2
AL - Albania 1
BB - Barbados 1
BG - Bulgaria 1
BZ - Belize 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
GT - Guatemala 1
HT - Haiti 1
HU - Ungheria 1
IL - Israele 1
KH - Cambogia 1
KR - Corea 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
PR - Porto Rico 1
PY - Paraguay 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
SX - ???statistics.table.value.countryCode.SX??? 1
TH - Thailandia 1
TN - Tunisia 1
TR - Turchia 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.777
Salva come PNG Salva come JPEG
Città #
Genoa 2.006
Vado Ligure 412
San Jose 246
Genova 224
Ashburn 160
Singapore 150
Rapallo 114
New York 81
Beijing 65
Council Bluffs 64
Lauterbourg 54
Hanoi 50
Ho Chi Minh City 44
Boardman 34
Los Angeles 34
Santa Clara 33
Hong Kong 32
Rome 32
Chicago 28
Milan 24
Frankfurt am Main 21
Helsinki 21
Lappeenranta 18
Buffalo 17
Toronto 16
Dallas 15
Naples 15
Orem 14
Turin 13
Bologna 11
St Louis 11
Mexico City 10
Phoenix 10
Tianjin 10
Atlanta 9
Da Nang 9
Haiphong 9
Montreal 9
Tokyo 9
Camaiore 8
Dublin 8
Charlotte 7
Hamilton 7
Bordighera 6
Brescia 6
Brooklyn 6
Memphis 6
Stockton 6
Washington 6
Bari 5
Florence 5
Strafford 5
Warsaw 5
Boston 4
Can Tho 4
Guangzhou 4
Houston 4
Kingston 4
Kyiv 4
Las Vegas 4
Livermore 4
Manchester 4
Meshoppen 4
Miami 4
Orlando 4
Pensacola 4
Philadelphia 4
Portland 4
Princeton 4
San Francisco 4
Seattle 4
São Paulo 4
Tampa 4
Tashkent 4
Verona 4
Vienna 4
Biên Hòa 3
Buenos Aires 3
Cagliari 3
Cairo 3
Cardiff 3
Catania 3
Greensboro 3
Hinton 3
Hải Dương 3
Jacksonville 3
Jersey City 3
Kansas City 3
London 3
Madison 3
Managua 3
Marseille 3
Messina 3
Miano 3
Oklahoma City 3
Pescara 3
Piscataway 3
Poplar 3
Reggio Emilia 3
Sacramento 3
Totale 4.384
Salva come PNG Salva come JPEG
Nome #
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features 169
Comparison of the Safety and Efficacy of Ustekinumab and Vedolizumab in Patients with Crohn’s Disease: A Systematic Review and Meta-Analysis of Propensity Score Matched Cohort Studies 147
Expression of Epidermal Growth Factor receptor (EGFR) in Systemic Sclerosis patients (SSc) and Gastro-oesophageal Reflux Disease (GORD) 141
PCSK9 inhibitors for treating hypercholesterolemia 139
Diet and nutraceutical supplementation in dyslipidemic patients: First results of an italian single center real‐world retrospective analysis 136
Hepatic Elastometry and Glissonian Line in the Assessment of Liver Fibrosis 135
Association between esophageal motor disorders and pulmonary involvement in patients affected by systemic sclerosis: a retrospective study 130
CLINICAL AND ENDOSCOPIC-HISTOLOGICAL FEATURES OF MULTIFOCAL AND CORPUS-RESTRICTED ATROPHIC GASTRITIS PATIENTS WITH NON-CARDIA GASTRIC CANCER OR DYSPLASIA: A MULTICENTER, CROSS-SECTIONAL STUDY 124
Autoimmune chronic atrophic gastritis: association between chronic proton pump inhibitors use and more severe atrophy and gastric intestinal metaplasia 119
Long term follow-up of genetically confirmed patients with familial hypercholesterolemia treated with first and second-generation statins and then with PCSK9 monoclonal antibodies 115
Esophageal motor disorders across ages: A retrospective multicentric analysis 112
Effects of a mediterranean diet, dairy, and meat products on different phenotypes of dyslipidemia: A preliminary retrospective analysis 109
Evaluation of the efficacy of plant sterols supplement sterolip® ESI in patients with type IIA hypercholesterolemia in relation to Genetic variants modulating intestinal absorption of cholesterol 105
Effect of a common missense variant in LIPA gene on fatty liver disease and lipid phenotype: New perspectives from a single-center observational study 101
Clinical efficacy of eucaloric ketogenic nutrition in the COVID-19 cytokine storm: A retrospective analysis of mortality and intensive care unit admission 100
Effect of hiatal hernia and esophagogastric junction morphology on esophageal motility: Evidence from high‐resolution manometry studies 97
Applying Lyon consensus criteria in the work‐up of patients with extra‐oesophageal symptoms – A multicentre retrospective study 92
Letter to the Editor: Is CAD-LT score as a predictor of coronary artery disease following liver transplantation? 91
Albumin-bilirubin score in non-malignant liver diseases should be properly validated 90
Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study 89
Are Small Molecules Effective in Treating Inflammatory Pouch Disorders Following Ileal Pouch-Anal Anastomosis for Ulcerative Colitis? Here Is Where We Stand 87
The crohn's disease exclusion diet in adults with mild-to-moderate crohn’s disease activity: A real-world open-label randomized controlled trial 86
Evaluation of the pathophysiological association between the GERD and OSAS: Esophageal pH-monitoring results beyond Lyon criteria 85
Nutritional therapy for patients with coronavirus disease 2019 (COVID-19): Practical protocol from a single center highly affected by an outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection 84
Food Intolerances, Food Allergies and IBS: Lights and Shadows 84
Clopidogrel-Induced Eosinophilic Colitis 83
Characteristics and outcome of anti‐hepatitis D virus positive patients with hepatocellular carcinoma 83
The Clinical Spectrum of Gastroesophageal Reflux Disease: Facts and Fictions 83
Reduction of Fecal Calprotectin Levels Induced by a Short Course of Escherichia Coli Nissle is Associated with a Lower Likelihood of Disease Flares in Patients with Ulcerative Colitis in Clinical Remission 82
Diagnostic delay in achalasia 81
Second‐Line Treatment for Patients With Primary Biliary Cholangitis: A Systematic Review With Network Meta‐Analysis 80
From Dysbiosis to Hepatic Inflammation: A Narrative Review on the Diet-Microbiota-Liver Axis in Steatotic Liver Disease 80
Evaluating Vonoprazan for the treatment of erosive GERD and heartburn associated with GERD in adults 79
Absence of Viral Replication Is Associated With Improved Outcome in Anti‐HCV‐Positive Patients With Hepatocellular Carcinoma 75
Biliary reflux after bariatric surgery and after gastroesophageal surgery for gastroesophageal reflux disease 75
Endoscopic Management of Eosinophilic Esophagitis: A Narrative Review on Diagnosis and Treatment 74
Assessing the short-term prognosis of patients with cirrhosis using the DIC scores 74
Whey proteins inhibit food intake and tend to improve oxidative balance in obese zucker rats 74
Decline in LDL-C control in patients with dyslipidemia treated with PCSK9-inhibitors: The role of obesity in LDL-C target achievement 73
Patient journey in gastroesophageal reflux disease: real-world perspectives from Italian gastroenterologists, primary care physicians, and ENT specialists 73
Role of dietary intervention in patients with metabolic syndrome and {NAFLD}-{NASH} 72
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study 70
Distribution of esophageal inflammation in patients with eosinophilic esophagitis and its impact on diagnosis and outcome 68
Hepatocellular carcinoma in patients with Autoimmune Hepatitis 65
Safety and efficacy of venous thromboembolism prophylaxis in patients with cirrhosis: A systematic review and meta-analysis 65
The use of the Crohn's disease exclusion diet (CDED) in adults with Crohn's disease: A randomized controlled trial 64
Changing epidemiology of hepatocellular carcinoma in the Mediterranean area: a challenge for surveillance? 64
Lipoprotein(a) concentration, genetic variants, apo(a) isoform size, and cellular cholesterol efflux in patients with elevated Lp(a) and coronary heart disease submitted or not to lipoprotein apheresis: An Italian case-control multicenter study on Lp(a) 62
SAFETY AND EFFICACY OF ATEZOLIZUMAB/ BEVACIZUMAB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA AND IMPAIRED LIVER FUNCTION: A SYSTEMATIC REVIEW AND META-ANALYSIS 62
Editorial: Diagnosis of GERD in patients with extra‐oesophageal symptoms—still a long way to go… Authors' reply' 60
Diet in Inflammatory Bowel Diseases: Efficacy, Tolerability, and Microbiome Effects Toward Personalized Management 60
Exploring new noninvasive parameters to predict oesophageal varices in patients with NAFLD-associated compensated liver cirrhosis 57
Effects of glucagon-like PEPTIDE-1 receptor agonists on incidence of hepatocellular carcinoma and liver decompensation in patients with diabetes: A systematic review and META-analysis 56
Evaluation of adherence to Mediterranean diet, assessed by a food frequency questionnaire, in dyslipidemic patients and evaluation of dietary intervention efficacy 56
Surveillance for hepatocellular carcinoma in patients with Primary Biliary Cholangitis: for all or just for some? 55
Expanding Insights on Ambulatory Reflux Monitoring: Future Directions and Clinical Integration 54
The levels of lipoprotein (a) in the modulation of carotid atherosclerosis risk in a group of patients with metabolic syndrome in primary prevention 53
Role of prokinetics in ineffective esophageal motility: A call for broader consideration and future innovations 52
Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis 51
Prevalence of Dysphagia and Its Health Implications Among Elderly Residents in Long-Term Care Facilities in the Liguria Region (Italy): An Observational Cohort Study 51
Lenvatinib Is Highly Effective in Patients with Hepatocellular Carcinoma Related to Both Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Etiology: A Propensity Score Analysis 48
Eosinophilic esophagitis is the leading cause of dysphagia in an outpatient setting 48
Autoimmune Hepatitis-Associated Hepatocellular Carcinoma: Clarifying the Evidence-A Reply 47
Is global score better than a single histological parameter for assessing microscopic esophagitis? 46
Updated treatment options for gastroesophageal reflux disease in children: practical guide for clinician 45
Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study 43
Immune checkpoint inhibitors in malignancies after liver transplantation: a systematic review and pooled analysis 42
Dietary and Nutraceutical Interventions for Functional Dyspepsia: A Narrative Review 37
Recurrence rate, features, and outcome after hepatocellular carcinoma curative resection or ablation according to the IMbrave050 criteria: a real-world study 37
Assessment of Esophagogastric Junction Barrier Function With the Supine‐Upright Transition of the Chicago Classification Protocol 36
Minimally invasive hepatectomy vs. thermoablation for single small (≤3 cm) hepatocellular carcinoma: A weighted real-life national comparison 33
null 30
Resolution of Hepatitis Delta Virus-related Cryoglobulinemic Vasculitis with the Use of Bulevirtide: a Case Report 30
Abnormal Milan Score and Compromised Esophageal Mucosal Integrity Stratify Gastroesophageal Reflux Disease Severity 29
The promise and pitfalls of Emerging Potassium-Competitive Acid Blockers for the treatment of Gastroesophageal reflux disease 28
Pharmacological management of gastro-esophageal reflux disease: state of the art in 2024 27
Sustained Virologic Response and Prognosis in HCV-related Hepatocellular Carcinoma: Lessons from Complementary Cohorts 26
The Therapeutic Pipeline for Eosinophilic Esophagitis: Current Landscape and Future Directions 25
Topical Protection of Esophageal Mucosa as a New Treatment of GERD 25
Evaluation of the diagnostic accuracy of two esophageal biopsy sites compared to three in histological follow-up of eosinophilic esophagitis – A multicentric study 24
Health inequalities in patients with cirrhosis: investigating the impact of material deprivation on patients’ outcomes. 24
Optimizing bracnh-duct intraductal papillary mucinous neoplasms surveillance: data-driven dimensional grouping for risk stratification and cost-effectiveness. The PACMANS Study 23
Comparative efficacy of initial treatment strategies in patients with TACE-unsuitable hepatocellular carcinoma 21
Combined Lyon and Milan Scores Predict Gerd Management Outcome Better Than Either Score Alone or Their Individual Components 21
Optimal Assessment, Treatment, and Monitoring of Adults with Eosinophilic Esophagitis: Strategies to Improve Outcomes 20
Recurrent hepatic encephalopathy after abdominal surgery in a non-cirrhotic patient: a case report. 17
Chronic Liver Disease, Liver Damage, and Liver Failure after Hypoabsorptive Bariatric Surgery: A Dose-Dependent Relationship and Multisystemic Consequences 16
Corrigendum to “Esophageal motility disorders among elderly patients: An international multicenter study” [Digestive and Liver Disease 57 (2025) 1615-1621] 15
Esophageal and Oropharyngeal Dysphagia: Clinical Recommendations From the United European Gastroenterology and European Society for Neurogastroenterology and Motility 14
Effectiveness and Safety of Orodispersible Budesonide for Eosinophilic Esophagitis: A Multicenter Real-World Study 12
Esophageal motility disorders among elderly patients: An international multicenter study 12
It takes two to tango: Preserving liver function competes with response to systemic therapy in patients with HCC and decompensated cirrhosis 10
The Milan Score Predicts Objective Gastroesophageal Reflux Disease in Patients With Type 2 Esophagogastric Junction 9
Mean Nocturnal Baseline Impedance in Gastroesophageal Reflux Disease: Considerations on the Study by Lee et al 8
Research gaps in eosinophilic esophagitis: unanswered questions and future directions 5
Esophageal Function Testing Identifies Barrett’s Esophagus Patients With Pathological Acid Exposure at Risk for Neoplasia 4
Totale 6.070
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.882
article - articoli 20.882
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.764
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022125 7 0 0 4 15 12 0 29 21 13 5 19
2022/2023150 17 19 3 5 22 19 13 11 19 1 17 4
2023/2024275 9 21 2 32 15 31 23 14 22 21 28 57
2024/20251.253 59 53 50 91 136 111 111 231 52 41 170 148
2025/20263.841 296 98 349 336 387 210 388 194 333 491 347 412
2026/2027310 310 0 0 0 0 0 0 0 0 0 0 0
Totale 6.070